Sensus Healthcare, Inc. (SRTS) Tops Q4 EPS by 2c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. EXPE
3. ARM
4. BROS
5. FIS
6. QCOM
7. DDOG
8. EW
9. ZG
10. W

Go back to Sensus Healthcare, Inc. (SRTS) Tops Q4 EPS by 2c, Revenues Beat

Sensus Healthcare Fourth Quarter Financial Results Feature Record Revenue and Continued Double-digit Growth

February 14, 2019 4:02 PM EST

BOCA RATON, Fla., Feb. 14, 2019 /PRNewswire/ -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces financial results for the three and 12 months ended December 31, 2018.

Highlights from the fourth quarter of 2018 include (all comparisons are with the fourth quarter of 2017, unless otherwise indicated):

Continued double-digit growth with revenues of $8.1 million, up 25% Net income of $0.1 million, or $0.01 per share, compared to $(0.4) million net loss, or $(0.03) per share Adjusted EBITDA, a non-GAAP financial measure, also turned positive... More